DIGITAL HEALTH MONITORING DEVICES MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024 - 2031)
Digital Health Monitoring Devices Market, By Product Type (Wearable Devices, Remote Monitoring Devices Software & Services), By Technology (Wireless Health , Mobile Health, Telehealth , and Electronic Health Records Or Electronic Medical Records), By Application (Chronic Disease Management, Fitness and Wellness Monitoring, and Mental Health Monitoring), By Age Group (Adult, Geriatric, and Pediatric), By End User (Hospitals & Clinics, Home Settings, Nursing Homes, Ambulatory Surgery Centers, Rehabilitation centers, etc., and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
On April 4, 2024, Royal Philips, a global leader in health technology, announced a strategic partnership with, smartQare, a healthcare technology company, to integrate smartQare's viQtor solution into Philips' clinical patient monitoring platforms
In November 2023, AstraZeneca, a global pharmaceutical leader, launched Evinova, a health-tech business aimed at accelerating innovation in the life sciences sector. Operating as a separate entity within AstraZeneca, Evinova offers globally scaled digital health solutions to optimize clinical trial design and delivery, thereby reducing the time and cost of developing new medicines.
In April 2023, Honeywell, a multinational conglomerate known for technology and innovation, introduced a real-time health monitoring system that captures and records patients' vital signs both in hospital settings and remotely
In October 2023, Dozee, an India-based health-tech startup, introduced the 'Dozee Pro Ex,' an ambulatory connected patient monitoring system, equipped with wireless wearable sensors. This system enables continuous monitoring of vital signs—including ECG rhythm, blood pressure, heart rate, oxygen saturation, respiration rate, and temperature—across various care settings such as hospital beds, ambulatory environments, and home care.
In July 2022, Medtronic plc, a global leader in medical technology, announced the acquisition of Verily Life Sciences, a subsidiary of Alphabet Inc., specializing in digital health technologies. This strategic move aims to enhance Medtronic plc's portfolio in digital health monitoring devices, leveraging Verily Life Sciences' expertise to develop innovative solutions for managing chronic diseases.